Enanta Pharmaceuticals Inc. buy Rodman & Renshaw
Start price
26.03.26
/
50%
€10.60
Target price
26.03.27
€17.30
Performance (%)
12.26%
Price
08:10
?
Summary
This prediction is currently active. The prediction currently has a performance of 12.26%. This prediction currently runs until 26.03.27. The prediction end date can be changed by Rodman___Renshaw at any time. Rodman___Renshaw has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Enanta Pharmaceuticals Inc. | 3.540% |
| iShares Core DAX® | 3,02 % |
| iShares Nasdaq 100 | 3,56 % |
| iShares Nikkei 225® | 6,62 % |
| iShares S&P 500 | 2,64 % |
Comments by Rodman___Renshaw for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals (ENTA) is now covered by Rodman & Renshaw. They set a "buy" rating and a $20.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat